How often does Fulcrum Therapeutics move more than the options market prices?

0 of the last 7 reports moved at least as far as the implied move.

FULCNasdaqPharmaceutical Preparations

Fulcrum Therapeutics, Inc. (FULC) earnings date, market-implied expected move, and options open interest by expiry

3.77

+0.02 · +0.67%

post 3.77 0.00%

Closed16:00 ET

Open3.83Volume776,313Mkt cap$287.6MEPS-1.21

Day3.75 – 3.8324%52-wk2.83 – 15.747%

FULC

Fulcrum Therapeutics, Inc.

OpenVolumeMkt capP/EEPSDiv yield

Day – 52-wk –

Expected move

No implied move.

Expected move

Inputs

Next report

Nov 9

before open · in 5 days

est.Q3 FY26

Calendar

Next report

Last report

−1.53%

vs ±19.3% implied · ×0.08

shaded = implied · ▲▼ = realized

Apr 27 '26 · confirmed

Implied vs realized

Linked news

5dSNY · customerSanofi Q3 sales €14,444 million, business EPS €3.55; upgrades 2026 guidance

News

Largest filed tie

13F top-10 QoQ

+40.57%

shares held · 10 largest managers

13F · Jun 30 '26128d lag

154 managers

Top fund weight

0.01%

FULC weight · IWM

N-PORTJun 30 '26

3 funds

Last reportshaded = implied▲▼ = realized× = |realized| ÷ implied

Fulcrum Therapeutics (FULC) is expected to report on Nov 9 before open (estimated date).

Implied vs realized

8 reports

0 of 7≥ implied

avg implied: ±26.2%
avg realized: ±7.2%

Nov 13 '24Nov 13 '24confirmed—▼−2.20%—

Jan 13 '25Jan 13 '25confirmed±17.6%▼−4.58%×0.26

Feb 25 '25Feb 25 '25confirmed±16.3%0.00%×0.00

May 1 '25May 1 '25confirmed±36.6%▲+13.77%×0.38

Jul 29 '25Jul 29 '25confirmed±44.9%▼−2.82%×0.06

Oct 29 '25Oct 29 '25confirmed±18.7%▼−6.40%×0.34

Feb 24 '26Feb 24 '26confirmed±29.8%▼−21.21%×0.71

Q1 FY26Apr 27 '26confirmed±19.3%▼−1.53%×0.08

quarterimplied−45%0+45%realized×

Q1 FY26±19.3%▼−1.53%×0.08

Feb '26±29.8%

Shaded = implied · tick ▲▼ = realized · × = |realized| ÷ impliedSource: options EOD · implied at prior close · realized close to close

Implied vs realized

Positioning

OI · 3 expiries · Nov 3 close

0.08OI · 3 expiries · Nov 3 closeP/C open interest · Dec 18 · first expiry after the report

PUTS · chgexpiry · days · P/CCALLS · chgP/C

3620%Dec 1844d4,3830%

3,0490%Jan 1572d0.506,1050%0.50

3,8820%Mar 19135d11.493380%11.49

ExpiryPutsCallsP/C

Dec 1844d3620%4,3830%0.08

Jan 1572d3,0490%6,1050%0.50

Mar 19135d3,8820%3380%11.49

Hatched = puts · solid = calls · bars scaled per expiry · chg = OI vs prior sessionSource: options EOD

Positioning

Linked exposure

No implied move.

Linked exposure

Revenue flow

per later filingQ2 FY24

69.26%per later filingnet margin

Revenue$80M—

Gross profit$80M100.00%—

Operating income$52M65.61%+275.95%

Pre-tax income$55M+306.21%

Net income$55M69.26%+306.21%

Cost of revenue$0—

Operating expenses$28M−7.80%

Other income$3M−1.59%

Source: SEC filings · standardized · QE Jun 30 '24 · bars = % of revenue

Revenue flow

Intraday

15m bars

Hatch = extended hours · ▯ up · ▮ downSource: market data · 16:00 ET

Intraday

Event sensitivity

FOMC ×1.11· ±3.9% vs ±3.5% · 24 releases

eventrelease day|move|up · n×base

FOMCrate decision±3.9%10 of 24×1.11

NFPjobs report±3.2%8 of 10×0.90

GDPgross domestic product±3.0%12 of 19×0.86

PCEpersonal income & outlays±3.0%8 of 19×0.86

CPROFcorporate profits±2.5%8 of 12×0.70

PPIproducer prices±2.4%4 of 10×0.67

CPIconsumer prices±2.1%4 of 10×0.59

Bar = avg |move| to ±4% · tick = ±3.5% avg day · ×base = |move| ÷ ±3.5% · min 6 releases

Earnings history

EPS -0.34 · consensus —

Quarter	Reported	EPS	Consensus
Q2 FY26	—	-0.34	—
Q1 FY26	Apr 27 '26 · confirmed	-0.25	—

Source: filed financials

Methodology

ties · implied moves · holdersMethod